86-10-65907696About Drug Regulatory and Medical Affairs Working Group
A) Vision
Build RDPAC Rx WG as partner of Chinese health authorities to benefit the needs of Chinese public health via encouraging drug innovation in China
B) Mission
1.To expedite the access of innovative medications for patients in China.
2.To facilitate constructive dialogue with key stakeholders.
3.To improve the competency of member companies' professionals and share best practices.
C) Organization
Under the leadership of the sponsor from RDPAC Executive Committee and the Rx WG Steering Committee mainly formulated by EC Sponsor and Work Streams' Leaders, there are four Work Streams in place, they are
1.Regulatory Affairs Work Stream
2.Clinical Operation Work Stream
3.Bio Work Stream covering both preventive and therapeutic biological
4.Pharmacovigilence Work Stream
Each Work Stream contains representatives from member companies. In principle, one member company has one representative so as to ensure one company has one voice. Elected from them, Core Members are formed with the accountabilities to
1.consistently participate in and contribute to the discussion and/or decision-making process,
2.make the best effort to fully understand the background of the issues and help explore the best possible positions/solutions for the WG /Industry,
3.contribute or help secure resources necessary to advance the WG agenda, and
4.be committed to seeking consensus and alignment among the WG, and if applicable, within the Industry.
For RDPAC members, please visit
